AU-011 is named as a drug or biological intervention in 2 clinical trials in our USA trial register, 1 of which is recruiting. The lead sponsor is Aura Biosciences. Registered phases: Phase 2 and Phase 1. Conditions studied include Eye Cancer; Primary Cancer; Non-muscle-invasive Bladder Cancer.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06643884 | Suprachoroidal Administration in Subjects With Metastases to the Choroid (ClinicalTrials.gov ↗) Eye Cancer, Primary Cancer |
Phase 2 | Recruiting |
| NCT05483868 | A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer (ClinicalTrials.gov ↗) Non-muscle-invasive Bladder Cancer, NMIBC, Non-Muscle Invasive Bladder Carcinoma |
Phase 1 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Eye Cancer | 1 |
| Primary Cancer | 1 |
| Non-muscle-invasive Bladder Cancer | 1 |
| NMIBC | 1 |
| Non-Muscle Invasive Bladder Carcinoma | 1 |
| Non-Muscle Invasive Bladder Neoplasms | 1 |
| Lead sponsor | Trials |
|---|---|
| Aura Biosciences | 2 |
| Register | AU-011 trials |
|---|---|
| Clinical trials in USA | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how AU-011 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists AU-011 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.